{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-003873","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.915027+00:00","generated_at":"2026-05-28T06:08:57.893064+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Achieve Life Sciences appoints Nancy Phelan and Kristen Slaoui to board; Himes resigns","bullets":["Dr. Vaughn Himes resigned from board effective Jan 6, 2025; no disagreement; will continue consulting.","Board appointed Nancy R. Phelan and Kristen B. Slaoui, Ph.D. as directors, effective Jan 6, 2025.","Each new director receives $40,000 annual retainer for FY2025 and stock option for 47,250 shares (3-yr vest).","Additionally, annual equity option for 31,500 shares vesting over one year, subject to continued service."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-003873","json":"https://secwatch.observer/filing/0000950170-25-003873.json","markdown":"https://secwatch.observer/filing/0000950170-25-003873.md","text":"https://secwatch.observer/filing/0000950170-25-003873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000095017025003873/0000950170-25-003873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000095017025003873/achv-20250106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T06:08:57.893064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29642575ab","claim":"Kristen B. Slaoui was appointed as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025003873/0000950170-25-003873-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5868b1c4ad","claim":"Vaughn Himes resigned as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"On January 6, 2025, Dr. Vaughn Himes informed the board of directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”), that he has elected to resign from his position as a member of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025003873/0000950170-25-003873-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b691522c5f","claim":"Nancy R. Phelan was appointed as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025003873/0000950170-25-003873-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}